India has an estimated 77 million people with Diabetes, which makes it the second most affected in the world, after China. One in six people (17%) in the world with diabetes is from India. Diabetes is one of the most challenging diseases for medical science to cure like other systemic diseases, as it has more serious complications due to negligence in management.

Modern medical science treats the condition with Oral hypoglycemic agents and Insulin to manage high blood sugar levels. The patient must take medicines to control blood sugar levels for a lifelong period. Though high blood sugar levels are managed by oral hypoglycemic agents and insulin, long-term use can cause many side effects like GI discomfort, heartburn, polyuria, etc. Hence, there is a scope for Ayurveda treatment for the management of high blood sugar levels.

The drugs in the trial formulation have been described by Acharya Sushruta collectively as Salasaradi Gana having action by their Kapha – Medoshoshan properties .

Haritaki is mainly of Kasaya Rasa, Ushna, Ruksa Guna. It acts as Kaphgna, these qualities of Haritaki acts as a cleanser and it also improves digestion. Same as in Diabetes (Prameha) there is Dusti of Medovaha Srotas and Dhatvagni, especially Mandya. Hence there is a need for Dravya which is of Usṇa, Rukṣa Gunas with Lekhan & Shoshan properties to cleanse the Medovaha Stratos and to increase the Dhatvagni.

So, as per this concept, it is decided to use Haritaki processed in Salsaradi Gana Dravya Kwath 7 times to sharpen the action of Haritaki with Rasayan property. That’s why this research plan has been designed as per Rasayan Vidhi with Aarohi-Avarohi Krama of the drug during the trial period.

Vijaysaradi Kwath contains mainly Tikta Kashaya Rasa and has Rukshana properties Tikta Rasa has Kledameda- vasa-majja-lasika Shoshana properties 5 and is known to be successfully used for the treatment of Madhumeha.